However, it appears that Berobenatide provides similar or better weight-loss benefits to competing GLP-1 drugs
On the other hand, in the SUSTAIN 6 trial, the effects on plasma lipids of the most powerful of the GLP-1RAs, semaglutide, were not remarkable
The Science Behind Tirzepatide As Mounjaros Active Ingredient The active ingredient in Mounjaro is tirzepatide, a novel injectable therapy developed to manage type 2 diabetes and now gaining momentum in the treatment of obesity
ascites and encephalopathy) and, if required, can support patients by ensuring diuretic therapy is optimised, infection prophylaxis is initiated and salt is restricted through dietary adjustments
That sounds impossibly short for a compound that produces cognitive benefits lasting weeks beyond the final dose